论文信息 - THYROID COMPLICATIONS OF CANCER THERAPY - AN INCREASING CHALLENGE. - 字舞流文

THYROID COMPLICATIONS OF CANCER THERAPY - AN INCREASING CHALLENGE.

[1] Wasim A. Samara,et al. Recurrent Painless Thyroiditis With Sequential Thyrotoxicosis and Hypothyroidism After 2 Courses of Lenalidomide , 2016 .

[2] P. Larsen,et al. Thyroid dysfunction from antineoplastic agents. , 2011, Journal of the National Cancer Institute.

[3] S. Sleijfer,et al. Sunitinib-induced hypothyroidism is due to induction of type 3 deiodinase activity and thyroidal capillary regression. , 2011, The Journal of clinical endocrinology and metabolism.

[4] J. Desai,et al. Hypothyroidism after Sunitinib Treatment for Patients with Gastrointestinal Stromal Tumors , 2006, Annals of Internal Medicine.

[5] Angus G. Dalgleish,et al. The evolution of thalidomide and its IMiD derivatives as anticancer agents , 2004, Nature Reviews Cancer.